Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Xeloda
Active Ingredient(s): Capecitabine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer(s): Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire,
United Kingdom
Note: This product has consent that expires on 5 August 2003.
Product: Xeloda
Active Ingredient(s): Capecitabine 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer(s): Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire,
United Kingdom
Note: This product has consent that expires on 5 August 2003.
Dated this 21st day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).